TMCO4: A Potential Drug Target and Biomarker for Transmembrane and Coiled-Coil Domains 4

Target Name: TMCO4

NCBI ID: G255104

TMCO4

TMCO4: A Potential Drug Target and Biomarker for Transmembrane and Coiled-Coil Domains 4

TMCO4 (Transmembrane and Coiled-Coil Domains 4) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and developmental defects. TMCO4 is a transmembrane protein that is involved in various signaling pathways, including G protein-coupled receptor (GPCR) signaling, neurotrophic signaling, and cell adhesion. Its unique structure, which consists of a transmembrane domain and a coiled-coil domain, makes it a unique protein that is worth exploring as a drug target and biomarker.

Structure and Function

TMCO4 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and pancreas. Its protein structure is characterized by a transmembrane domain and a coiled-coil domain. The transmembrane domain is responsible for the protein's transmembrane properties, while the coiled-coil domain is responsible for its stability and functions as a protein.

The transmembrane domain of TMCO4 is made up of 125 amino acid residues and has a highly conserved topology. It is involved in the formation of an ion channel that is responsible for the protein's transmembrane properties. This channel allows TMCO4 to regulate the movement of ions and molecules through the membrane, which is essential for its function in signaling pathways.

The coiled-coil domain of TMCO4 is made up of 13 amino acid residues and is responsible for the protein's stability and functions as a protein. This domain is involved in the formation of a stable coiled structure that can interact with other proteins and molecules. The coiled-coil domain of TMCO4 is also involved in the regulation of its function in signaling pathways.

TMCO4 is involved in various signaling pathways, including GPCR signaling, neurotrophic signaling, and cell adhesion. Its transmembrane and coiled-coil domains are involved in the regulation of these signaling pathways, which are essential for the protein's function in various physiological processes.

Potential Drug Target

TMCO4 has been identified as a potential drug target due to its involvement in various signaling pathways. Its transmembrane and coiled-coil domains are involved in the regulation of ion channels, which are critical for the regulation of electrical signals in the body. This suggests that TMCO4 may be a good candidate for a drug that targets ion channels and modulates electrical signals in the body.

TMCO4 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and developmental defects. Its unique structure and function make it a valuable tool for the development of new diagnostic tools and therapeutic approaches for these diseases.

Biomarker Potential

TMCO4 has been identified as a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and developmental defects. Its unique structure and function make it a valuable tool for the development of new diagnostic tools and therapeutic approaches for these diseases.

For example, TMCO4 has been shown to be involved in the regulation of ion channels, which are critical for the regulation of electrical signals in the body. This suggests that TMCO4 may be a good candidate for a drug that targets ion channels and modulates electrical signals in the body.

In addition, TMCO4 has been shown to be involved in the regulation of neurotrophic signaling, which is involved in the development and maintenance of neural circuits in the brain. This suggests that TM

Protein Name: Transmembrane And Coiled-coil Domains 4

The "TMCO4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMCO4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets